New York University Langone Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2022

  1. PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy

    Clinical Cancer Research, Vol. 28, Núm. 15, pp. 3182-3184

2021

  1. Siglec-15 as an emerging target for next-generation cancer immunotherapy

    Clinical Cancer Research, Vol. 27, Núm. 3, pp. 680-688

2020

  1. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy

    Nature, Vol. 583, Núm. 7817, pp. 609-614

2019

  1. Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non-small cell lung cancer using spatially resolved and multiparametric single-cell analysis

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4663-4673